Interleukin 17B (IL-17B) is a member of the IL-17 cytokine family, which plays a crucial role in immune responses and inflammatory processes. The IL-17 family consists of six cytokines: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E, and IL-17F. These cytokines are known for their involvement in host defense mechanisms and various inflammatory diseases .
Recombinant Human IL-17B is typically produced in an E. coli expression system and is a non-disulfide-linked homodimer consisting of two 161 amino acid polypeptide chains. The molecular weight of this recombinant protein is approximately 36.6 kDa . It is highly purified, with a purity of ≥ 98% as determined by SDS-PAGE gel and HPLC analyses . The endotoxin concentration is less than 1 EU/µg .
IL-17B is known to stimulate the release of pro-inflammatory cytokines such as TNF alpha (TNF) and IL1 beta (IL1B) from monocytic cell lines . It also induces IL-8 secretion in human PBMCs (Peripheral Blood Mononuclear Cells) and HepG2 human hepatocellular carcinoma cells . The activity of IL-17B is measured by its ability to induce IL-8 secretion, with an effective dose (ED50) ranging from 0.4 to 2 µg/mL .
Immunohistochemical analysis has shown that IL-17B is primarily localized to neuronal cell bodies . It plays a significant role in inflammation and bone growth . The IL-17B/IL-17RB pathway has also been implicated in cancer, highlighting its importance in various physiological and pathological processes .